CDISC Proudly Announces the Registration of a Branch Office of the CDISC European Foundation in Hong Kong
The Clinical Data Interchange Standards Consortium
(CDISC) is delighted to announce the opening of a branch of the CDISC European Foundation in Hong Kong. Hong Kong was chosen for its centralized location in the fastest growing market in the world, and represents a significant opportunity for CDISC to expand the global adoption of CDISC standards. “Our presence in Hong Kong reflects our commitment to our existing and new members in the Asia-Pacific region. This includes existing member companies in such Asia-Pacific countries as Japan, China, South Korea, India, Thailand, Singapore and Australia. We at CDISC want to ensure that our members in this region feel that they have an outlet and are represented,” stated Sheila Leaman, CDISC Director of Global Relations.
After a vision that took nine months to come to fruition, the registration of the Hong Kong branch was finalized on 7 May 2013. “We are extremely pleased to announce our new CDISC Hong Kong branch,” said Dr. Rebecca Kush, CDISC President and CEO. “After discussions within CDISC Operations last year, we determined to proceed through our CDISC European Foundation entity to allow for a swifter process, and are glad that we will now have representation for our members in the Asia-Pacific region.”
Incidentally, after CDISC’s successful Interchange in Singapore in February 2013, attendees were interested in continuing to have a CDISC conference in the region. As such, CDISC is planning to have the next CDISC Asia-Pacific Interchange in Hong Kong in the summer of 2014 as a way to continue to provide value to our members and spread the message about CDISC standards in the region.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
